Why do most medical marijuana states continue to discriminate against patients? Editor’s note: This article is by Kate Harveston, a frequent contributor to the Kight on Cannabis blog. In it, she discusses the unjust situation in which most medical marijuana patients are restricted in the state-level jobs that they can obtain. It is a follow up to her prior article on Nevada’s employment protections for marijuana users. Kate has a passion for cannabis policy issues…

Top 5 cannabis predictions for 2020. Making predictions about the new year is always more fun than recapping the prior one. And, while making new year’s predictions is more of a parlor trick than a serious pursuit, 2020 is clearly poised to be a historic and consequential year for cannabis. I have been traveling abroad this past week with my family, including a trip to Amsterdam, the unofficial capital of cannabis. I used the time…

Prop 65 requires warnings for cannabis products, including hemp and CBD. INTRODUCTION- PROP 65 PROBABLY IMPACTS YOUR BUSINESS Formally named the “Safe Drinking Water and Toxic Enforcement Act of 1986”, Prop 65 requires businesses to provide warnings to Californians about significant exposures to chemicals that cause cancer, birth defects, or other reproductive harm. Failure to comply can subject a business to severe fines and civil judgments. Since its enactment over 30 years ago, Prop 65’s…

hemp tests for the 2018 and 2019 growing seasons, as analyzed by Clearwater Biotech, reveal alarming details about the viability of current genetics under a “Total THC” standard. Editor’s note: This article is a modified version of a comment to the USDA written by Marion Snyder, PhD, Chief Scientific Officer of Clearwater Biotech. In this article, Dr. Snyder distills her analysis of hemp testing during the 2018 and 2019 growing seasons. Based on…

The USDA’s release of its interim final rule (Rule) regarding hemp production is flawed. The comment period is open through December 30, 2019. I strongly encourage you to comment online, which you can do by clicking here. We at Kight on Cannabis have written extensively about the Rule. You can read our articles by clicking here, here, here, here, and here. I was recently asked by my friends at Darling…

The FDA issued another round of warning letters to CBD companies this week. Editor’s note: In this article, Kight Law attorney Kamran Aryah discusses the latest round of warning letters from the FDA to CBD companies. As Kamran notes, the letters do not represent a policy shift, though they are part of a ramping up of enforcement activity that appears to be timed with the USDA’s release of its interim final rule regarding hemp production.…